carboplatin

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

carboplatin
Oct 20, 2024, 19:52 | Blog
Stephen V Liu: Case report in Annals of Oncology of patients with NUT carcinoma responding to lurbinectedin
Stephen V Liu shared a post on X, about recent case report published in Annals…
Sep 17, 2024, 10:36 | Insight
Elisabetta Bonzano: First-line carboplatin-cyclophosphamid versus paclitaxel for mTNBC
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: “ First-line carboplatin-cyclophosphamid…
Aug 4, 2024, 05:15 | Insight
Yüksel Ürün: U.S. FDA expands endometrial cancer indication for dostarlimab-gxly with chemotherapy
Yüksel Ürün shared on X: "U.S. FDA expands endometrial cancer indication for dostarlimab-gxly with chemotherapy.…
Jul 11, 2024, 11:33 | Blog
Neeraj Agarwal: Outstanding talk by Evan Yu on treatment of advanced prostate cancer
Neeraj Agarwal shared a post on X: “Enjoyed the outstanding talk by Evan Yu at…
Jun 23, 2024, 04:42 | Drugs
Tanja Obradovich: This month marks Keytruda reaching 40 approved indications in the US
Tanja Obradovich shared on LinkedIn: “This month (as of June 17th) marks Keytruda reaching 40…
Jun 22, 2024, 05:04 | Blog
Yüksel Ürün: Carboplatin plus docataxel for patients with biallelic HRR gene alterations in metastatic castration-resistant prostate cancer
Yüksel Ürün shared a post on X: “The ABCD Trial shows promising results with carboplatin…
Jun 12, 2024, 15:34 | Insight
Piotr Wysocki: Dostarlimab combined with chemotherapy in dMMR/MSI-H advanced endometrial cancer patietns
Piotr Wysocki recently posted on LinkedIn: "Part 1 of the RUBY trial (NCT03981796) evaluated the…
Jun 4, 2024, 16:28 | Societies
Erika Hamilton: Data that pCR translates to outcome in TNBC
Erika Hamilton shared a post on X: “PEARLY: Adriamycin Cyclophosphamide (AC) to Taxane versus AC…
May 23, 2024, 13:08 | Blog
Miguel Bronchud: Too many different treatments options for some cancer patients? Or not enough?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “Too many different treatments options…
May 23, 2024, 07:56 | Blog
Chinmay Jani: Let's explore EGFR Exon 20 Insertion NSCLC with a twist of Miami flair!
Chinmay Jani, Clinical Fellow, Hematology & Oncology at University of Miami, made the following post…
May 15, 2024, 13:45 | Blog
Sergio Cifuentes Canaval: Exciting insights from the MRI-guided optimization study in HER2+ breast cancer!
Sergio Cifuentes Canaval, Student Fellow at National Autonomous University of Mexico, shared a post on LinkedIn:…
May 14, 2024, 15:36 | Insight
Andy Hahn: Congrats to Ana Aparicio and team on this trial of 192 men with mCRPC
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared on X: “Congratulations to…
Apr 28, 2024, 15:35 | Opinion
Zainab Shinkafi-Bagudu: Hosting the Merck Sharp and Dohme (MSD) team
Zainab Shinkafi-Bagudu shared on LinkedIn; "This week, I had the pleasure of hosting the Merck Sharp…
Apr 5, 2024, 08:35 | Insight
Bishal Gyawali: Why 'number of cancer drugs approved' is a poor surrogate for measuring policy success
Alvaro Carrascal, Assistant Professor at University at Albany School of Public Health, shared a post…
Jul 5, 2023, 05:23 | Drugs
Cancer drug shortages continue - Stephen V Liu
Cancer drug shortages continue. Carboplatin, cisplatin, capecitabine, methotrexate, azacitadine - the list continues to grow…
Jun 7, 2023, 03:37 | Drugs
Addressing Cisplatin and Carboplatin Shortages: Insights from FDA Oncology Center of Excellence Director
In this open access discussion, Richard Pazdur, Director of the FDA Oncology Center of Excellence,…
Jun 2, 2023, 06:11 | Drugs
Urgent Call for Action: Shortages of Essential Cancer Drugs in the US Threaten Patient Care
Joanna Kemp."14 cancer drugs are currently in shortage in the US including carboplatin, methotrexate and…
All: 17 Posts: 1 - 100
Special Coverage